Agilent Technologies Inc. logo

Agilent Technologies Inc. (A)

Market Open
21 Jul, 19:50
NYSE NYSE
$
132. 93
+2.67
+2.0497%
$
36.79B Market Cap
- P/E Ratio
1.02% Div Yield
1.54M Volume
- Eps
$ 130.26
Previous Close
Add Transaction
Day Range
125 134.74
Year Range
108.35 160.27
Want to track A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Stay Ahead of the Game With Agilent (A) Q4 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With Agilent (A) Q4 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.

Zacks | 1 year ago
Why Is Agilent (A) Up 1.2% Since Last Earnings Report?

Why Is Agilent (A) Up 1.2% Since Last Earnings Report?

Agilent (A) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Agilent Technologies Thrives From the Forever Chemicals Crackdown

Agilent Technologies Thrives From the Forever Chemicals Crackdown

Agilent Technologies Inc. NYSE: A is a diversified global leader in the life sciences, diagnostics, and applied chemical markets. The company provides equipment systems, instruments, software and services that enable researchers and scientists to make breakthroughs in the medical sector and various fields.

Marketbeat | 1 year ago
Agilent (A) Reliance on International Sales: What Investors Need to Know

Agilent (A) Reliance on International Sales: What Investors Need to Know

Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks | 1 year ago
Agilent (A) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y

Agilent (A) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y

Agilent's (A) fiscal third-quarter results reflect weakness across the Pharma, Food, Chemical and Advanced Materials, and Academic and Government markets.

Zacks | 1 year ago
These Analysts Boost Their Forecasts On Agilent After Strong Earnings

These Analysts Boost Their Forecasts On Agilent After Strong Earnings

Agilent Technologies, Inc. A posted better-than-expected third-quarter earnings and issued upbeat fourth-quarter guidance on Wednesday.

Benzinga | 1 year ago
A Stock Earnings: Agilent Technologies Beats EPS, Beats Revenue for Q3 2024

A Stock Earnings: Agilent Technologies Beats EPS, Beats Revenue for Q3 2024

Agilent Technologies (NYSE: A ) just reported results for the third quarter of 2024. Agilent Technologies reported earnings per share of $1.32.

Investorplace | 1 year ago
Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript

Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript

Agilent Technologies, Inc. (NYSE:A ) Q3 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Conference Call Participants Operator Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 Earnings Call. My name is Regina and I will be coordinating your call today.

Seekingalpha | 1 year ago
Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates

Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.43 per share a year ago.

Zacks | 1 year ago
Agilent beats quarterly results on strong demand from biotech clients

Agilent beats quarterly results on strong demand from biotech clients

Agilent Technologies on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies.

Reuters | 1 year ago
Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns

Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns

Agilent Technologies (A) launches J&W 5Q GC/MS Columns to address the growing demand for modern laboratories.

Zacks | 1 year ago
Loading...
Load More